Image
PrEP Uâ„¢ HIV-Prevention Education for University Student Health Centers

Stacy Smallwood, PhD, MPH; David Malebranche, MD, MPH; Damon Johnson, Jr.

Jointly provided by Postgraduate Institute for Medicine and Integritas Communications.

 

This activity is supported by an independent educational grant from Gilead Sciences, Inc.

Faculty

Stacy Smallwood, PhD, MPH
Assistant Professor
Department of Community Health Behavior and Education
Jiann-Ping Hsu College of Public Health
Affiliate Faculty, Women’s, Gender & Sexual Studies Program
College of Arts and Humanities
Diversity & Inclusion Faculty Fellow, Centers for Teaching & Technology
Georgia Southern University
Statesboro, Georgia

David Malebranche, MD, MPH
Associate Professor
Morehouse School of Medicine
Atlanta, Georgia

Damon Johnson, Jr.
Program Manager
Georgia AIDS Education & Training Center
Atlanta, Georgia

Target Audience

This activity is intended for student healthcare providers (MDs, DOs, NPs, PAs, nurses), social workers, counselors, peer educators, and other community stakeholders engaged in the care of patients with human immunodeficiency virus (HIV) in a college or university health center setting.

Program Overview

PrEP U™: HIV-Prevention Education for University Student Health Centers is a comprehensive professional and lay-leadership training program to help you meet the health needs of your university community. This online enduring activity for professionals from university health centers seeks to help participants understand the changing landscape of HIV in the southeast, particularly among the university community, and implement comprehensive HIV-prevention strategies. Topics to be covered include: HIV epidemiology and risk, overcoming stigma and social barriers, screening and pre-exposure prophylaxis (PrEP), and strategies and resources for implementing an educational and awareness campaign to prevent HIV infection and increase the use of PrEP on your university campus.

Educational Objectives

Upon completion of this activity, participants will be better able to:

  1. Demonstrate knowledge of key epidemiologic data on HIV incidence and burden in the Southern United States.
  2. Determine patients’ PrEP eligibility through HIV testing, sexual-history taking, and appropriate laboratory testing. Describe evidence-based HIV PrEP principles and guideline-driven practices with regard to initiating treatment and on-treatment monitoring.
  3. Implement Centers for Disease Control and Prevention recommendations for comprehensive HIV prevention for at-risk candidates.
  4. Engage healthcare providers, administrators, students, and/or other pertinent community or campus stakeholders in the implementation of campus-specific, comprehensive HIV-prevention strategies.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine (PIM) and Integritas Communications Group. PIM is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

PIM designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours. 

CME Inquiries/Special Needs

For questions regarding the accreditation of this program, please contact PIM at www.pimed.com.

Disclosure of Conflicts of Interest

PIM requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Stacy Smallwood, PhD, MPH: Dr. Smallwood has nothing to disclose.
David Malebranche, MD, MPH: Fees for Non-CME Services Received Directly from a Commercial Interest (e.g. speakers’ bureaus): Gilead Sciences, Inc.
Damon Johnson, Jr.: Mr. Johnson has nothing to disclose.

The PIM planners and managers have nothing to disclose. The Integritas Communications planners and managers have nothing to disclose.

Method of Participation and Request for Credit

There are no fees for participating and receiving CME/CE credit for this activity. During the period December 31, 2018 through December 31, 2019, participants must read the learning objectives and faculty disclosures and study the educational activity. 

If you wish to receive acknowledgment for completing this activity, please complete the post-test and evaluation. Upon successfully completing the post-test with a score of 75% or better and the activity evaluation, your certificate will be made available immediately. 

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management.  Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

 

Click "Begin Activity" to acknowledge that you have reviewed the preamble information for this activity.

Begin Activity

credit amount 1.50

credit type CME/CE

release 12/31/2018

expiration 12/31/2019

type Webcast